Navigation Links
PAREXEL Strengthens Late Phase and Observational Research Capabilities With Expert Team to Help Biopharma Meet Commercialization Goals
Date:11/23/2011

al, and other risks.
Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2011 as filed with the SEC on November 9, 2011, which "Risk Factors" discussion is incorporated by reference in this press release.  The Company specifically disclaims any obligation to update these forward-looking statements in the future.  These forward-looking statements should not be relied upon as representing the Company's estimates or views as of any date subsequent to the date of this press release.

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL International Corporation, Perceptive Informatics, Inc. or their respective owners and are hereby acknowledged.Contacts: Jennifer Baird, Senior Director of Public RelationsKim Leadley/Gene CarozzaPAREXEL International

PAN CommunicationsTel: +781-434-4409

Tel: + 617-502-4300Email: Jennifer.Baird@PAREXEL.com

Email: PAREXEL@pancomm.com

 
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PAREXEL Advances Early Phase CNS Research Capabilities With Leading Medical Imaging Technology
2. UCB and PAREXEL Sign Strategic Partnership Agreement
3. PAREXEL International to Present at Lazard Capital Markets Healthcare Conference and Citi Small/Mid Cap Conference
4. PAREXEL Commercialization Experts to Present Best-Practice Approaches for Demonstrating Product Value at ISPOR Annual European Congress
5. PAREXEL Reports First Quarter Fiscal Year 2012 Financial Results
6. PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value
7. New PAREXEL Podcast Series to Deliver Clinical Development and Commercialization Thought Leadership
8. PAREXEL and National University of Singapore Establish Program in Singapore to Meet Increasing Demand in Asia for Clinical Research Talent
9. PAREXEL Announces Date of First Quarter Fiscal Year 2012 Earnings Release and Conference Call
10. Experts to Provide Successful Strategies for Global Biopharmaceutical Development and Commercialization at PAREXEL Tokyo Seminar
11. PAREXEL International Reports Fourth Quarter and Fiscal Year 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... their reach nationally by providing customers with on-site 17025 accredited pipette calibrations. ... ... ... ... Photo - http://photos.prnewswire.com/prnh/20150601/219758 As an industry-leading ...
(Date:6/2/2015)... , June 2, 2015  Ashion™ Advanced ... rapidly evolving genomic medicine industry, announced today ... service using Syapse Precision Medicine Platform. AIM ... (PMCs) with partner regional healthcare systems, providing ... genomic interpretation, education, and operational support. AIM ...
(Date:6/2/2015)... Mass., June 2, 2015 Today, Accuratus ... Capital Partners (Ampersand), announced the acquisition of the ... BioPharma Inc. (Array).  Accuratus was formed in July ... MN acquired Microtest Labs of Agawam, ... microbial testing services to the medical device and ...
Breaking Medicine Technology:Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 2Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 3Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 4Ashion Advanced Individual Medicine Chooses Syapse to Enable Genomics-Based Cancer Care in the Community 2Ashion Advanced Individual Medicine Chooses Syapse to Enable Genomics-Based Cancer Care in the Community 3Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 2Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 3
... 2012 Stereotaxis, Inc. (NASDAQ:   STXS) today ... European market the V-Sono™ intracardiac echocardiography manipulator module ... Designed to manipulate accessory devices such as variable ... Vdrive™ platform combines magnetic navigation with the Odyssey™ ...
... (NASDAQ: KERX ), a biopharmaceutical company focused ... pharmaceutical products for the treatment of renal disease (the ... ended March 31, 2012. At March 31, ... and investment securities of $31.0 million, as compared to ...
Cached Medicine Technology:Stereotaxis Releases V-Sono™ Intracardiac Echocardiography Module for the Vdrive™ Remote Navigation System 2Stereotaxis Releases V-Sono™ Intracardiac Echocardiography Module for the Vdrive™ Remote Navigation System 3Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results 3Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results 4
(Date:6/2/2015)... June 02, 2015 Did you wish Ryder ... to get him, his family isn’t asking for presents, but ... team walking in Saturday’s Cure HHT DC Walk. , Ryder ... that causes malformed blood vessels leading to sudden and extreme ... appear when Ryder was 3 years old in the form ...
(Date:6/2/2015)... On October 1, 2015 the transition to ICD-10 ... , On Monday, June 1st Congressman Kevin Brady, ... and Means Committee, and 12 members of the Committee ... Services, urging the administration to provide a smooth transition ... is the newest coding system for healthcare professionals to ...
(Date:6/2/2015)... Cochrane, Alberta (PRWEB) June 02, 2015 ... technology, announces the market entry of two new products ... and Kinomap Trainer announce new wireless interoperability in their ... training experience for cyclists. Tacx has implemented the FE-C ... trainer models as well as its new indoor training ...
(Date:6/2/2015)... 2015 ZOOM+, the Portland-based health innovator ... Insurance, announced today the opening of its on-demand ZOOM+Smile ... a three-in-one complete dental exam, cleaning and whitening in ... Like all ZOOM+ services, ZOOM+Smile can be scheduled by ... dentist office be as inviting as your favorite coffee ...
(Date:6/2/2015)... Mo. (PRWEB) June 02, 2015 With a ... Senior Living & Health Care has hired Leslie Young ... expansion of human resource initiatives to better understand and respond ... families in Tutera’s 47 communities in 13 states across the ... highest levels of personalized support to our residents, we are ...
Breaking Medicine News(10 mins):Health News:Six-Year-Old Walks to Bring Awareness to Genetic Disease 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4Health News:First ANT FE-C Enabled Fitness Products Enter Market 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 3Health News:ZOOM+ Opens Its First On-Demand ZOOM+Smile Studio and Reinvents the Dental Exam 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 3Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 4
... Saing Ratha lies semi-conscious, her thin body shaking with fever as ... ice under her arms. ,Her 10-year-old bother Saing ... in this spartan rural clinic. ,Both have been struck ... in the first six months of this year as during the ...
... Thursday they will immunise 63 million children against measles in ... virulent disease is one of the deadliest threats to young ... day, but vaccination coverage here is currently only 69 percent. ... world. I think it will show a lot of results," ...
... Scientists of the Department of Personality, Evaluation and Psychological ... have studied how some psychological variables such as ... are related to sexual desire in human beings. ... there are very few reliable and valid instruments in ...
... men and women with multiple sclerosis (MS) equally transmit the ... ,The research contradicts the findings of a recent study, ... to transmit the risk of developing MS to their children. ... affected with MS. Of the 8,401 children in those families, ...
... harried by the super bug Clostridium difficile (C diff), good news ... the hospital infection, researchers say. ,Clostridium difficile (C. ... of around 3% of adults and 66% of children. ... antibiotics that are used to treat other health conditions can interfere ...
... than 2% incontinence are the striking results of a ... innovative treatment for prostate cancer. HDR (high dose ... technology was shown to be just as effective as ... common side-effects of impotence and incontinence. ,Conventional Therapy ...
Cached Medicine News:Health News:Dengue Deaths Sweeping Cambodia Highlight Healthcare Failures 2Health News:Dengue Deaths Sweeping Cambodia Highlight Healthcare Failures 3Health News:Pakistan to Launch World's Biggest Anti-measles Drive 2Health News:Sexual Fantasies Play an Important Role in Boosting Desire 2Health News:Sexual Fantasies Play an Important Role in Boosting Desire 3Health News:Probiotic Drinks can Stave Off Hospital Infection 2Health News:Impotence and Incontinence Greatly Reduced With New Prostate Cancer Treatment 2Health News:Impotence and Incontinence Greatly Reduced With New Prostate Cancer Treatment 3Health News:Impotence and Incontinence Greatly Reduced With New Prostate Cancer Treatment 4
The Closer vascular closure device is a suture mediated closure system. It has a sheath-like profile and easy positioning. It has an innovative design which involves the needles outside the artery an...
Femoral selective diagnostic catheter.The material used is polyurethane (DUCOR). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
These are coronary angiographic catheters used for selective coronary bypass angiography. The catheters curve configuration is ideally suited to select the internal mammary artery....
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Medicine Products: